COCHLEATE DRUG DELIVERY SYSTEMS: AN APPROACH TO THEIR CHARACTERIZATION

Archive ouverte

Lipa-Castro, Antonio | Legrand, François-Xavier | Barratt, Gillian

Edité par CCSD -

Cochleate systems formed from phospholipids have very useful properties as drug delivery systems with sustained release capabilities, which are able to improve bioavailability and efficacy, reduce toxicity and increase the shelf-life of encapsulated molecules. These nanometric or micrometric structures are usually obtained after interaction of negatively charged liposomes with a positively charged bridging agent. Many different methods are now available to prepare cochleates and there are also numerous techniques that can be used to characterize them, some of which can be easily applied while others require more sophisticated equipment or analysis. The present review describes the important features of this drug delivery system; including their structural properties and potential applications, as well as a brief account of methods for their preparation and an extensive description of the techniques used for their characterization. This information could guide formulators in their choice of methods of characterization that would be best suited to their needs in terms of time, precision and technological difficulty.

Suggestions

Du même auteur

Cochleate formulations of Amphotericin b designed for oral administration using a naturally occurring phospholipid

Archive ouverte | Lipa-Castro, Antonio | CCSD

International audience. The purpose of this work was to formulate the poor soluble antifungal and antiparasitic agent Amphotericin B (AmB) in cost-effective lipid-based formulations suitable for oral use in developi...

Cochleate formulations of Amphotericin b designed for oral administration using a naturally occurring phospholipid

Archive ouverte | Lipa-Castro, Antonio | CCSD

International audience. Co chleates Am photeri cin B Or al bioa va il ab il ity Ca co2 cell s sy nchro tron SA XS Ci rcula r dichro is m ABSTRACT The pu rpose of this work is to formu late the poor soluble antifunga...

Formulation and in vitro efficacy of liposomes containing the Hsp90 inhibitor 6BrCaQ in prostate cancer cells

Archive ouverte | Sauvage, Félix | CCSD

International audience

Chargement des enrichissements...